0001209191-15-019706.txt : 20150228 0001209191-15-019706.hdr.sgml : 20150227 20150227171944 ACCESSION NUMBER: 0001209191-15-019706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150226 FILED AS OF DATE: 20150227 DATE AS OF CHANGE: 20150227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furfine Eric Steven CENTRAL INDEX KEY: 0001590220 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 15660620 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-26 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001590220 Furfine Eric Steven C/O ELEVEN BIOTHERAPEUTICS, INC., 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 0 1 0 0 Chief Science Officer Stock Option 10.39 2015-02-26 4 A 0 52500 0.00 A 2025-02-25 Common Stock 52500 217854 D This option was granted on February 26, 2015 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2015. /s/ Eric Steven. Furfine 2015-02-26